Search Close Search
Search Close Search
Page Menu

Marcus Ruscetti, Ph.D.


Assistant Professor
   
Ph.D.: 2015, University of California, Los Angeles
Postdoctoral research: Memorial Sloan Kettering Cancer Center
   
Office: UMass Chan Medical School
364 Plantation Street, LRB-625
Worcester, MA 01605
Phone:  
Email: Marcus.Ruscetti@umassmed.edu

Research

Our laboratory is studying how tumors, and in particular prostate and pancreatic cancers, escape immune surveillance during disease progression, and trying to restore tumor suppressive pathways lost early during tumor inception for cancer immunotherapy. We use innovative mouse modeling approaches, combined with genome editing, screening, and sequencing modalities, to dissect and manipulate tumor suppressor pathways, to elucidate tumor-immune interactions, and to evaluate new drug combinations for treating aggressive solid tumors. We are particularly interested in studying a tumor suppressive pathway called cellular senescence, a physiological stress-response program leading to proliferative arrest and secretion of pleiotropic factors that modulate immune responses.

View the Ruscetti Lab website

Rotation Projects

Rotation projects are available on several topics, including:

  1. Dissecting the transcriptional and epigenetic regulation of a tumor suppressive process known as cellular senescence in different tumor contexts.
  2. Harnessing the senescence-associated secretory phenotype (SASP) to reengage immune surveillance and overcome immunotherapy resistance in pancreatic cancer.
  3. Elucidating and targeting genetic mediators of immune escape in prostate cancer metastasis using an innovative mouse modeling approach.
  4. Uncovering mechanisms of resistance to RAS targeted therapies and senescence and immune surveillance bypass in lung cancer.

Please contact Dr. Ruscetti for more detail.

Positions Available

Postdoctoral fellow positions are available for candidates with recent Ph.D. and/or M.D. degrees in Cancer Biology, Genetics, Immunology, or related fields. Applicants should be highly motivated with strong molecular biology skills, cell culture experience, and at least one first-author publication. Mouse experience is preferred but not required. Applicants should send their CV, summary of previous research, reprints of relevant publications, and the names of three references to Dr. Marcus Ruscetti.

Lab Technician/Research Assistant positions are available for motivated candidates with a Bachelor’s degree in biology or a related field and previous research experience. Candidates with experience in molecular biology techniques such as DNA isolation, PCR, gel electrophoresis, and cloning, as well as mammalian cell culture are especially encouraged to apply. Send a CV, Cover Letter, and names of two-three references to Dr. Ruscetti.

UMass Chan News Highlights

Getting Results…
  • PhD candidate Katherine Murphy receives NIH grant for innovative prostate cancer research

    PhD candidate Katherine Murphy receives NIH grant for innovative prostate cancer research

    PhD candidate Katherine Murphy received a Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship for her pancreatic cancer research.

    Read more
  • Morningside Graduate School of Biomedical Sciences honors students during annual awards ceremony

    Morningside Graduate School of Biomedical Sciences honors students during annual awards ceremony

    The Morningside Graduate School of Biomedical Sciences at UMass Chan Medical School honored student scientists for outstanding research and leadership qualities on May 29.

    Read more
  • UMass Chan faculty present translational research at BRIDGE Fund Innovation Showcase

    UMass Chan faculty present translational research at BRIDGE Fund Innovation Showcase

    UMass Chan supports translational research from faculty with internal funding mechanism.

    Read more
  • UMass Chan researchers develop dual therapeutic that holds promise as pancreatic cancer treatment

    UMass Chan researchers develop dual therapeutic that holds promise as pancreatic cancer treatment

    UMass Chan Medical School scientists Marcus Ruscetti, PhD, and Prabhani Atukorale, PhD, have developed a new, dual immunotherapy approach that may potentially change the way clinicians treat pancreatic cancer.  

    Read more
  • UMass Chan BRIDGE Fund commits $2M in six faculty projects

    UMass Chan BRIDGE Fund commits $2M in six faculty projects

    BRIDGE Innovation and Business Development at UMass Chan Medical School has set aside nearly $2 million in funding for six faculty-led research projects that hold promise for translation to clinical application and commercialization.  

    Read more
  • PODCAST: Marcus Ruscetti shares his research journey in cancer biology

    PODCAST: Marcus Ruscetti shares his research journey in cancer biology

    Marcus Ruscetti, PhD, resisted following in his parents scientist footsteps but ended up in a career dedicated to cancer research in and out of the lab.

    Transcript

     

    Read more
  • Marcus Ruscetti receives American Cancer Society award for prostate cancer research

    Marcus Ruscetti receives American Cancer Society award for prostate cancer research

    The Research Scholar Grant will support Dr. Ruscetti’s research on senescent cells and their role in tumor progression and immune suppression in prostate cancer.

    Read more
  • UMass Cancer Center funds five UMass Chan research projects

    UMass Cancer Center funds five UMass Chan research projects

    The UMass Cancer Center Pilot Project Program has awarded seed grants to five UMass Chan Medical School research projects to enable investigators to gather pilot data for external cancer-focused funding.

    Read more